Mounjaro (Tirzepatide) Prescribing Update

From 23 June 2025, following approval by NICE, tirzepatide (Mounjaro®) will be available in the NHS for eligible patients who meet the strict, nationally-set, criteria. 

PCMS Logo

Leading Change Through Innovation

Autism

Autism is a lifelong condition that affects how people communicate and interact with others.

It affects people in different ways but most autistic people see, hear and experience the world differently from people without autism.

Autistic people may be given a diagnosis of Autism Spectrum Disorder or Asperger Syndrome.